Dyslipidemia testing: Why, for whom and when.

Area of Science:

• Cardiology
• Preventive Medicine
• Clinical Lipidology

Background:

• Dyslipidemia represents a significant risk factor for the development of cardiovascular disease (CVD).
• Early identification and management of lipid disorders are essential for primary CVD prevention.
• Current guidelines offer varying recommendations for lipid testing protocols.

Purpose of the Study:

• To elucidate the rationale ('why') behind lipid testing in clinical practice.
• To define the target populations ('who') and optimal timing ('when') for lipid screening.
• To highlight discrepancies in international guidelines regarding dyslipidemia assessment.

Main Methods:

• This review synthesizes current evidence and guidelines on lipid testing.
• Comparative analysis of European, English, and American dyslipidemia screening recommendations.
• Emphasis on the principles of cardiovascular risk assessment.

Main Results:

• Lipid testing is fundamental for identifying individuals who can benefit from primary CVD prevention strategies.
• Significant variations exist among major international guidelines concerning the recommended age and methodology for lipid testing.
• Established thresholds and frequencies for risk assessment remain undefined, underscoring the need for individualized approaches.

Conclusions:

• Lipid testing is a cornerstone of cardiovascular risk assessment and primary prevention.
• Harmonization of international guidelines for lipid testing is warranted.
• Personalized patient communication and consideration of individual circumstances are paramount in making decisions about lipid testing.